AB230368
BAY-299, TAF1 and BRD1 inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
MW 429.5 Da, Purity >98%. Potent and selective bromodomain inhibitor of TAF1 (IC50 = 8-13 nM) and BRD1 (IC50 = 6-67 nM). More than 30-fold selective versus BRD9 and ATAD2. More than 300-fold selective versus BRD4. Inhibits BRD1 (IC50 = 0.58 μM) and TAF1 (IC50 = 0.9 μM) binding to Histone H4 in cell-based assays; also inhibits BRD1 (IC50 = 0.83 μM) and TAF1 (IC50 = 1.4 μM) binding to Histone H3.3.
1 Images
- Chemical Structure
Lab
Chemical Structure - BAY-299, TAF1 and BRD1 inhibitor (AB230368)
2D chemical structure image of ab230368, BAY-299, TAF1 and BRD1 inhibitor
Properties and storage information
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Biochemistry 61:1774-1789 PubMed35976792
2022
Molecular Insights into the Recognition of Acetylated Histone Modifications by the BRPF2 Bromodomain.
Applications
Unspecified application
Species
Unspecified reactive species
Soumen Barman,Anirban Roy,Jyotirmayee Padhan,Babu Sudhamalla
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com